Immediate Impact

1 by Nobel laureates 4 from Science/Nature 61 standout
Sub-graph 1 of 22

Citing Papers

Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2023 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
3 intermediate papers

Works of Amanda Gordon being referenced

Prospective evaluation of front-line chemo-immunotherapy (C-IT) with oregovomab (2 alternative dosing schedules) carboplatin-paclitaxel (C-P) in advanced ovarian cancer (OC)
2007
Phase III Randomized Trial of Docetaxel-Carboplatin Versus Paclitaxel-Carboplatin as First-line Chemotherapy for Ovarian Carcinoma
2004

Author Peers

Author Last Decade Papers Cites
Amanda Gordon 312 115 102 392 247 15 786
E. Kutarska 430 91 29 280 173 17 921
Joan Sorich 433 65 28 249 203 31 751
Creasman Wt 297 75 15 358 188 19 914
M.L. Rothenberg 362 67 56 209 95 14 769
Hyun S. Shvartsman 187 79 43 427 112 10 762
Joseph J. Kash 265 141 81 468 313 10 938
Saverio Danese 400 95 22 258 208 31 858
Jie Li 294 94 88 127 101 16 784
E. Sandberg 375 72 21 202 218 16 736
R J Barrett 396 83 34 386 212 13 890

All Works

Loading papers...

Rankless by CCL
2026